ScreenerHero
ALPREPredilife S.A.
EPA · FR · Healthcare · Diagnostics & Research · predilife.com
1.110EUR-1.77%Mkt Cap: 4.75M $P/E: —

Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a n…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1

Key Statistics

Company
Market Cap4.75M $
Enterprise Value10.04M $
Revenue (TTM)908.49K $
Gross Profit891.04K $
Net Income (TTM)-4.28M $
Revenue/Share0.2304 USD
Last Price1.110 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees20
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.85
EV/Revenue11.05
P/S5.33
P/B-0.27
EPS (TTM)-1.00
EPS (Forward)—
52W Range
0.90007% of range4.000
52W High4.000 EUR
52W Low0.9000 EUR
Profitability
Gross Margin98.08%
Oper. Margin-380.15%
EBITDA Margin0.00%
Profit Margin-470.74%
ROE56.91%
ROA-214.62%
Growth
Revenue Growth32.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.79M $
CapEx (TTM)2.21K $
FCF Margin-154.97%
FCF Yield-29.61%
Net Debt5.19M $
Net Debt/EBITDA-1.47
Balance Sheet
Debt/Equity-0.80
Current Ratio0.56
Quick Ratio0.55
Book Value/Sh-4.1460 EUR
Cash/Share0.1890 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.94M
Float—
Insiders50.95%
Institutions0.00%
Technical
SMA 501.754 (-36.7%)
SMA 2002.781 (-60.1%)
Beta0.25
S&P 52W Chg18.16%
Avg Vol (30d)1.03K
Avg Vol (10d)742
Technical Indicators
RSI (14)35.1
MACD-0.1665
MACD Signal-0.2269
MACD Hist.+0.0604
BB Upper1.643 EUR
BB Middle1.234 EUR
BB Lower0.8260 EUR
BB Width66.16%
ATR (14)0.1080 EUR
Vol Ratio (20d)1.84x